Identification of a C3b-specific nanobody that does not bind C3 and blocks alternative pathway convertases
C3b-specific nanobodies are developed by generating phage libraries from llamas immunized with purified and surface-bound C3b and Functionally, UNbC3b-1 inhibits complement activity in the alternative pathway (AP), likely by preventing association between substrate C3 and the AP C3 convertase (C3bBb).